Journey Medical (DERM) Accounts Payables (2020 - 2025)
Historic Accounts Payables for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $11.6 million.
- Journey Medical's Accounts Payables fell 2465.61% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 2465.61%. This contributed to the annual value of $16.0 million for FY2024, which is 1156.54% down from last year.
- Per Journey Medical's latest filing, its Accounts Payables stood at $11.6 million for Q3 2025, which was down 2465.61% from $12.8 million recorded in Q2 2025.
- Over the past 5 years, Journey Medical's Accounts Payables peaked at $43.7 million during Q1 2023, and registered a low of $11.6 million during Q3 2025.
- For the 5-year period, Journey Medical's Accounts Payables averaged around $23.7 million, with its median value being $22.8 million (2021).
- In the last 5 years, Journey Medical's Accounts Payables soared by 114045.68% in 2021 and then crashed by 6485.64% in 2024.
- Quarter analysis of 5 years shows Journey Medical's Accounts Payables stood at $22.8 million in 2021, then surged by 60.31% to $36.6 million in 2022, then tumbled by 50.37% to $18.1 million in 2023, then decreased by 11.57% to $16.0 million in 2024, then dropped by 27.99% to $11.6 million in 2025.
- Its Accounts Payables stands at $11.6 million for Q3 2025, versus $12.8 million for Q2 2025 and $14.4 million for Q1 2025.